Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « chloroquine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
chitra < chloroquine < chloroquinone  Facettes :

List of bibliographic references indexed by chloroquine

Number of relevant bibliographic references: 278.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (2021) Daniel G. Dauner ; Kim Nichols DaunerSummary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic.
000002 (2021) Fabricio Souza Neves [Brésil]Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.
000033 (2021) Dania Altulea [Pays-Bas] ; Sjors Maassen [Pays-Bas] ; Maksim V. Baranov [Pays-Bas] ; Geert Van Den Bogaart [Pays-Bas]What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
000046 (2021) Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000050 (2021) Isabel S. Hernandes [Brésil] ; Haroldo C. Da Silva [Brésil] ; Hélio F. Dos Santos [Brésil] ; Wagner B. De Almeida [Brésil]Unveiling the Molecular Structure of Antimalarial Drugs Chloroquine and Hydroxychloroquine in Solution through Analysis of 1H NMR Chemical Shifts.
000061 (2021) Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana]Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
000068 (2021) Cassandra Doyno [États-Unis] ; Diana M. Sobieraj [États-Unis] ; William L. Baker [États-Unis]Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000100 (2021) Rana Aljadeed [Arabie saoudite]The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.
000138 (2021) Katharina Habler [Allemagne] ; Mathias Brügel [Allemagne] ; Daniel Teupser [Allemagne] ; Uwe Liebchen [Allemagne] ; Christina Scharf [Allemagne] ; Ulf Schönermarck [Allemagne] ; Michael Vogeser [Allemagne] ; Michael Paal [Allemagne]Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
000149 (2021) Amir Sarayani [États-Unis] ; Brian Cicali [États-Unis] ; Carl H. Henriksen [États-Unis] ; Joshua D. Brown [États-Unis]Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
000151 (2021) Fernando Luiz Barros Edington [Brésil] ; Sandra Rocha Gadellha [Brésil] ; Mittermayer Barreto Santiago [Brésil]Safety of treatment with chloroquine and hydroxychloroquine: A ten-year systematic review and meta-analysis.
000161 (2021) Eric Prommer [États-Unis]Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients.
000196 (2021) A J J. Lammers [Pays-Bas] ; R M Brohet [Pays-Bas] ; R E P. Theunissen [Pays-Bas] ; C. Koster [Pays-Bas] ; R. Rood [Pays-Bas] ; D W M. Verhagen [Pays-Bas] ; K. Brinkman [Pays-Bas] ; R J Hassing [Pays-Bas] ; A. Dofferhoff [Pays-Bas] ; R. El Moussaoui [Pays-Bas] ; G. Hermanides [Pays-Bas] ; J. Ellerbroek [Pays-Bas] ; N. Bokhizzou [Pays-Bas] ; H. Visser [Pays-Bas] ; M. Van Den Berge [Pays-Bas] ; H. Bax [Pays-Bas] ; D F Postma [Pays-Bas] ; P H P. Groeneveld [Pays-Bas]Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".
000199 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.
000200 (2021) Marijke Linschoten [Pays-Bas] ; Linda Nab [Pays-Bas] ; Iwan C C. Van Der Horst [Pays-Bas] ; Robert Tieleman [Pays-Bas] ; Folkert W. Asselbergs [Royaume-Uni]Response to "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".
000206 (2021) Justine Perez ; Matthieu Roustit ; Marion Lepelley ; Bruno Revol ; Jean-Luc Cracowski ; Charles KhouriReported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.
000207 (2021) Manya Prasad [Inde] ; Arunmozhimaran Elavarasi [Inde] ; Pramod Garg [Inde]Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
000234 (2021) Carlos Diaz-Arocutipa [Pérou] ; Ana Bra Ez-Condorena [Pérou] ; Adrian V. Hernandez [Pérou, États-Unis]QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
000243 (2021) Wei Tang [États-Unis] ; Yevgeniya Gartshteyn [États-Unis] ; Cathy Guo [États-Unis] ; Tommy Chen [États-Unis] ; Jon Giles [États-Unis] ; Anca Askanase [États-Unis]Prophylaxis of COVID-19 with Hydroxychloroquine and Chloroquine.
000249 (2021) Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine]Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "chloroquine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "chloroquine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    chloroquine
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021